Lite Strategy (LITS) Payables (2011 - 2026)
Lite Strategy (LITS) posted Payables of $262000.0 for Q1 2026, down 26.2% on a QoQ basis from $355000.0 in Q4 2025, and up 48.02% year-over-year from $177000.0 in Q1 2025.
Analysis
Lite Strategy (LITS) Payables (2011 - 2026) Analysis & Trends
Lite Strategy has reported Payables for 16 years, with the latest figure at $262000.0 in Q1 2026.
- On a quarterly basis, Payables rose 48.02% year-over-year to $262000.0 in Q1 2026; TTM through Mar 2026 was $262000.0, a 48.02% increase from a year earlier, with the FY2025 full-year figure at $176000.0, down 94.44% from the prior year.
- Payables was $262000.0 for Q1 2026 at Lite Strategy, down from $355000.0 in the prior quarter.
- The five-year high for Payables was $8.4 million in Q3 2022, with the low at $176000.0 in Q2 2025.
- Average Payables over 5 years is $3.1 million, with a median of $3.2 million recorded in 2024.
- The sharpest annual moves came in 2022 and 2025: Payables soared 48.21% in 2022, then tumbled 94.44% in 2025.
- Over 5 years, Payables stood at $4.1 million in 2022, then plunged by 66.12% to $1.4 million in 2023, then slumped by 56.75% to $596000.0 in 2024, then plunged by 40.44% to $355000.0 in 2025, then fell by 26.2% to $262000.0 in 2026.
- The last three Payables figures came in at $262000.0 (Q1 2026), $355000.0 (Q4 2025), and $503000.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 2.87 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 674.00 Mn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 429.50 Mn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 1.16 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 1.52 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 167.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 108.02 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 403.90 Mn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 25.08 Mn |
| 10 | Lite Strategy | 38.03 Mn | 30.49 Mn | - | 262,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 262,000.00 |
| Dec 31, 2025 | 355,000.00 |
| Sep 30, 2025 | 503,000.00 |
| Jun 30, 2025 | 176,000.00 |
| Mar 31, 2025 | 177,000.00 |
| Dec 31, 2024 | 596,000.00 |
| Sep 30, 2024 | 976,000.00 |
| Jun 30, 2024 | 3.17 Mn |
| Mar 31, 2024 | 3.18 Mn |
| Dec 31, 2023 | 1.38 Mn |
| Sep 30, 2023 | 3.22 Mn |
| Jun 30, 2023 | 6.13 Mn |
| Mar 31, 2023 | 4.39 Mn |
| Dec 31, 2022 | 4.07 Mn |
| Sep 30, 2022 | 8.42 Mn |
| Jun 30, 2022 | 7.92 Mn |
| Mar 31, 2022 | 8.26 Mn |
| Dec 31, 2021 | 6.26 Mn |
| Sep 30, 2021 | 8.47 Mn |
| Jun 30, 2021 | 6.36 Mn |